Use of erythropoietin in ophthalmology: a review.
Erythropoietin
Ocular diseases
Review
Journal
Survey of ophthalmology
ISSN: 1879-3304
Titre abrégé: Surv Ophthalmol
Pays: United States
ID NLM: 0404551
Informations de publication
Date de publication:
Historique:
received:
18
01
2021
revised:
08
06
2021
accepted:
14
06
2021
pubmed:
23
6
2021
medline:
31
3
2022
entrez:
22
6
2021
Statut:
ppublish
Résumé
Erythropoietin (EPO) is a glycoprotein hormone that regulates hematopoiesis in the human body. The presence of EPO and its receptors in different tissues indicates that this hormone has extramedullary effects in other tissues, including the eye. We focus on the biological roles of this hormone in the development and normal physiologic functions of the eye. Furthermore, we explore the role of EPO in the management of different ocular diseases - including diabetic retinopathy, retinopathy of prematurity, inherited retinal degeneration, branch and central retinal vein occlusion, retinal detachment, traumatic optic neuropathy, optic neuritis, methanol optic neuropathy, nonarteritic anterior ischemic optic neuropathy, glaucoma, and scleral necrosis.
Identifiants
pubmed: 34157346
pii: S0039-6257(21)00139-9
doi: 10.1016/j.survophthal.2021.06.002
pii:
doi:
Substances chimiques
Erythropoietin
11096-26-7
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
427-439Informations de copyright
Copyright © 2021. Published by Elsevier Inc.